Eton Pharma Chief Business Officer David Krempa reports disposal of 25,000 common shares valued at $1.63 million - ETON News | RalliesEton Pharma Chief Business Officer David Krempa reports disposal of 25,000 common shares valued at $1.63 million
E
ETON• Eton Pharmaceuticals insider share sale
- Eton Pharmaceuticals Chief Business Officer David Krempa sold 25,000 common shares on Aug. 24, 2026 at $65.07.
- The sale followed the exercise of 25,000 employee stock options at $7.31 on the same day.
- Directly owned common shares fell to 37,025 after the transactions.
- Employee stock options held increased to 70,000 following the exercise.
LFWD
•
